Incidence of thrombotic complications in critically ill ICU patients with COVID-19-Reference-Cited by-同舟云学术

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

Published:2020-07 Issue: Volume:191 Page:145-147
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Klok F.A.,Kruip M.J.H.A.,van der Meer N.J.M.,Arbous M.S.,Gommers D.A.M.P.J.,Kant K.M.,Kaptein F.H.J.,van Paassen J.,Stals M.A.M.,Huisman M.V.,Endeman H.

Funder

Bayer

Bristol-Myers Squibb

Boehringer-Ingelheim

Daiichi-Sankyo

MSD and Actelion

Dutch Heart foundation

Dutch Thrombosis association

ZonMW Dutch Healthcare Fund

Pfizer-BMS

Bayer Health Care

Aspen

Pfizer

Sobi

The Netherlands Organisation for Health Research and Development

Publisher

Elsevier BV

Subject

Hematology

Reference5 articles.

1. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study;Chen;Bmj,2020

2. Clinical characteristics of coronavirus disease 2019 in China;Guan;N. Engl. J. Med.,2020

3. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan;Wang,2020

4. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study;Zhou;Lancet,2020

5. How I treat disseminated intravascular coagulation;Levi;Blood,2018

Cited by 4298 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dyspnea and long COVID patients;The American Journal of the Medical Sciences;2024-10

2. A Dynamic, D-dimer-based Thromboprophylaxis Strategy in Patients with COVID-19;F1000Research;2024-09-04

3. Findings of Abdominal Computed Tomography In COVID-19 Patients with Abnormal Abdominal Symptoms In Siriraj Hospital;The ASEAN Journal of Radiology;2024-09-02

4. The Characteristics of Coronary Artery Lesions in COVID-19 Infected Patients With Coronary Artery Disease: An Optical Coherence Tomography Study;The American Journal of Cardiology;2024-09

5. Effect of amubarvimab-romlusevimab for treatment of severe COVID-19 in intensive care units: A retrospective cohort study;Heliyon;2024-09